Global Mirtazapine Drug Market Size, Share and Trends Analysis Report, By Type (15 mg Tablet, 30 mg Tablet, and 45 mg Tablet), By Application (Drug Store and Hospital), Forecast (2022-2028)

The global mirtazapine drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Mirtazapine drug is in the class of medications called antidepressants. It works by increasing brain activity to maintain mental balance. The global mirtazapine drug market is growing due to the increasing prevalence of depression and bipolar disorder patients globally. According to FDA, depression is considered a disabling illness that is expected to lead to suicidal thoughts among people. The off-label recommendation and prescription of anti-depressant and anti-anxiety drugs are driving the growth of the market. The market is also increasing due to the changing lifestyle and increasing societal pressures aid in the high suicidal tendencies, primarily among young adults that leads to depression. According to the World Health Organization 2021, it is estimated that 5% of the world’s adult population suffers from depression. Additionally, the research and development of major market players for the manufacturing of generic drugs as a substitute for the branded drug which will be cheaper but equally effective are boosting the growth of the global mirtazapine drug market in the forecast period.

For instance, According to the journal published by Multidisciplinary Digital Publishing Institute in September 2021, it states that mirtazapine drug is also used to treat Alzheimer’s disease patients. This is because Neuropsychiatric symptoms, such as depression and agitation, are strongly associated with Alzheimer’s disease that reduces the life quality of the patients. Thus, mirtazapine drug is prescribed to control the anxiety, agitation, and other depressive symptoms in these patients.

Some major players in the market include Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Zydus Group, and Sun Pharmaceutical Industries Ltd. among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new drug launches, to stay competitive in the market. For instance, In March 2019, VistaGen Therapeutics, a biopharmaceutical company started developing new general medicine to treat depression, social anxiety disorder, and central nervous system disease. Several other drugs are in the pipeline that is intended for the treatment of the suicidal and depressive disorder

Market Coverage

The market number available for – 2022-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered-

By Type

By Application

Regions Covered-

North America

Europe

Asia-Pacific

Rest of the World

Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Zydus Group, and Sun Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

Deviation from the pre-COVID-19 forecast

Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Mirtazapine Drug Market Report by Segment

By Type

15 mg Tablet

30 mg Tablet

45 mg Tablet

By Indication

Hospital

Drug Store

Global Mirtazapine Drug Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Rest of the World

Latin America

Middle East & Africa